Distribution of ABO Blood Groups and Their Association With Low Risk of Severe COVID-19 Infection in Patients

Minfei Peng, Shigao Huang, Qingqing Lv, Chaochao Chen, Jiajia Qin, Minmin He, Jie Yang, Shiyong Chen, Qi ZhaoResearch 2021 · DOI

Introduction

Early in the COVID-19 pandemic, identifying biological markers to predict disease severity was a critical priority for clinical triage. While age and comorbidities were quickly established as risk factors, the role of host genetics—specifically the ABO blood group system—remained an area of active debate. This retrospective study aimed to describe the ABO blood group distribution and its association with the risk of severe COVID-19 infection to help identify susceptible populations and develop a simple predictive decision system.

Methods

Researchers conducted a retrospective clinical study at the Taizhou Hospital of Zhejiang Province, China, covering the period from January 21 to February 20, 2020. The study utilized a primary clinical dataset of 220 patients:

  • Severe COVID-19: 32 patients
  • Non-severe COVID-19: 106 patients
  • Non-COVID-19 Control: 82 patients (suspected cases that tested negative via RT-PCR)

ABO blood groups were determined using an automated analyzer. The team also performed biochemical analyses, comparing laboratory indices such as liver enzymes (ALT) and tissue damage markers (LDH) between blood type O and non-O patients. Statistical modeling utilized Chi-square tests for categorical data and Odds Ratios (OR) with 95% confidence intervals to assess relative risk.

Results

Blood Group Distribution

The study found distinct trends in how blood groups were distributed across different clinical outcomes. While type O was prevalent in non-severe and control groups, its frequency was markedly lower in the severe category.

Distribution of ABO blood groups across patient severity and gender.

The "O" Advantage in Severe Cases

Statistical analysis confirmed that blood type O acts as a protective factor against severe disease progression. The data revealed a significant negative correlation between type O and severe infection, suggesting these individuals are less likely to require intensive clinical intervention.

Statistical association analysis between ABO blood groups and COVID-19 severity.

Key statistical findings include:

  • Risk Reduction: Patients with blood type O had a significantly lower risk of severe COVID-19 compared to other blood types (OR = 0.380, p = 0.044).
  • Gender-Specific Resilience: The protective effect was particularly pronounced in females. In the female cohort, type O was strongly associated with lower severity (p = 0.049).
  • Biochemical Validation: Type O patients exhibited significantly lower levels of Alanine Aminotransferase (ALT) and Lactate Dehydrogenase (LDH) compared to non-O patients. Since LDH is a marker for cell necrosis, its lower levels suggest less systemic damage to the liver and lungs in type O individuals.

Discussion and Conclusion

This study suggests that ABO blood groups may play a significant role in COVID-19 pathogenesis, with blood type O providing a degree of protection against severe clinical outcomes, especially in women. The authors hypothesize that this may be due to differences in humoral immune response profiles, as evidenced by lower CD19+ B cell ratios in type O patients.

Limitations

The authors acknowledge several constraints, including a relatively small sample size (n=220) and geographic homogeneity, as the cohort was limited to a single hospital in China. As an observational study, it identifies correlations but cannot definitively prove a causal mechanism. Future large-scale genomic studies are recommended to explore the direct interaction between blood group antigens and the SARS-CoV-2 virus.

Summary updated

Abstract

Abstract Background: To date, only few studies have focused on the correlation between ABO blood groups and COVID-19 infection risk, especially gender differences in infection risk. Our study aimed to describe the ABO blood group distribution and its association with risk of severe COVID-19 infection for effective identification of the susceptible population. Method: From January 21 to February 20, 2020, we compared the ABO blood group distribution and gender distribution and performed a correlation analysis in severe, non-severe, and non-COVID-19 patients. Results The results showed that the laboratory indices were significantly different between blood type O and non-blood-type-O COVID-19 patients. This indicated that patients of the type O blood group had a relatively lower risk of severe COVID-19 infection than patients of other blood types; in particular, females with blood type O had a lower risk of severe COVID-19 infection than males. Conclusion: Herein, we report a potentially simple prediction decision system to minimize the risk of severe COVID-19 infection based on blood type. Special attention should be paid to patients with blood types other than type O to minimize their risk of severe COVID-19 infection.
BibTeX
@inproceedings{peng2021distribution,
  author = {Minfei Peng and Shigao Huang and Qingqing Lv and Chaochao Chen and Jiajia Qin and Minmin He and Jie Yang and Shiyong Chen and Qi Zhao},
  title = {{Distribution of ABO\ Blood Groups and Their Association With Low Risk of Severe COVID-19 Infection in Patients}},
  booktitle = {Research},
  year = {2021},
  doi = {10.21203/rs.3.rs-139563/v1},
}
Figure